82
Views
224
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Translocation Products in Acute Myeloid Leukemia Activate the Wnt Signaling Pathway in Hematopoietic Cells

, , , , , , , , , , , , , , & show all
Pages 2890-2904 | Received 01 Aug 2003, Accepted 05 Jan 2004, Published online: 27 Mar 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (11)

Jiejin Qian, Xianbo Huang, Yinyin Zhang, Xiujin Ye & Wenbin Qian. (2020) γ-Catenin Overexpression in AML Patients May Promote Tumor Cell Survival via Activation of the Wnt/β-Catenin Axis. OncoTargets and Therapy 13, pages 1265-1276.
Read now
Jiadai Xu, Wei Wu, Wenyi Shen & Peng Liu. (2016) The clinical significance of γ-catenin in acute myeloid leukemia. OncoTargets and Therapy 9, pages 3861-3871.
Read now
Maria G Cortiguera, Ana Batlle-López, Marta Albajar, M Dolores Delgado & Javier León. (2015) MYC as therapeutic target in leukemia and lymphoma. Blood and Lymphatic Cancer: Targets and Therapy 5, pages 75-91.
Read now
Etienne De Braekeleer, Nathalie Douet-Guilbert & Marc De Braekeleer. (2014) RARA fusion genes in acute promyelocytic leukemia: a review. Expert Review of Hematology 7:3, pages 347-357.
Read now
Anamaria Orza, Daniel Casciano & Alexandru Biris. (2014) Nanomaterials for targeted drug delivery to cancer stem cells. Drug Metabolism Reviews 46:2, pages 191-206.
Read now
Yuan Fu, Huayuan Zhu, Wei Wu, Jiadai Xu, Tingmei Chen, Bei Xu, Sixuan Qian, Jianyong Li & Peng Liu. (2014) Clinical significance of lymphoid enhancer-binding factor 1 expression in acute myeloid leukemia. Leukemia & Lymphoma 55:2, pages 371-377.
Read now
Annette Romanski, Kerstin Schwarz, Maren Keller, Sarah Wietbrauk, Anja Vogel, Jessica Roos, Claudia Oancea, Boris Brill, Oliver H. Krämer, Hubert Serve, Martin Ruthardt & Gesine Bug. (2012) Deacetylase inhibitors modulate proliferation and self-renewal properties of leukemic stem and progenitor cells. Cell Cycle 11:17, pages 3219-3226.
Read now
Amy C. Moore, Joseph M. Amann, Christopher S. Williams, Emilios Tahinci, Tiffany E. Farmer, J. Andres Martinez, Genyan Yang, K. Scott Luce, Ethan Lee & Scott W. Hiebert. (2008) Myeloid Translocation Gene Family Members Associate with T-Cell Factors (TCFs) and Influence TCF-Dependent Transcription. Molecular and Cellular Biology 28:3, pages 977-987.
Read now
Ansgar Schmidt & Peter J. Koch. (2007) Desmosomes. Cell Adhesion & Migration 1:1, pages 28-32.
Read now
Lara Tickenbrock, Carsten Müller-Tidow, Wolfgang E Berdel & Hubert Serve. (2006) Emerging Flt3 kinase inhibitors in the treatment of leukaemia. Expert Opinion on Emerging Drugs 11:1, pages 153-165.
Read now
Carsten Müller-Tidow, Ping Ji, Sven Diederichs, Jenny Potratz, Nicole Bäumer, Gabriele Köhler, Thomas Cauvet, Chunaram Choudary, Tiffany van der Meer, Wan-Yu Iris Chan, Conrad Nieduszynski, William H. Colledge, Mark Carrington, H. Phillip Koeffler, Anja Restle, Lisa Wiesmüller, Joëlle Sobczak-Thépot, Wolfgang E. Berdel & Hubert Serve. (2004) The Cyclin A1-CDK2 Complex Regulates DNA Double-Strand Break Repair. Molecular and Cellular Biology 24:20, pages 8917-8928.
Read now

Articles from other publishers (213)

Kelsey A. Carpenter, Kate E. Thurlow, Sonya E.L. Craig & Stephanie Grainger. 2023. Wnt Signaling in Development and Disease. Wnt Signaling in Development and Disease 255 279 .
Akbar Muhammed Shahid, In Hwa Um, Mustafa Elshani, Ying Zhang & David James Harrison. (2022) NUC-7738 regulates β-catenin signalling resulting in reduced proliferation and self-renewal of AML cells. PLOS ONE 17:12, pages e0278209.
Crossref
Megan Wagstaff, Brandon Coke, Georgia R. HodgkissRhys G. Morgan. (2022) Targeting β-catenin in acute myeloid leukaemia: past, present, and future perspectives. Bioscience Reports 42:4.
Crossref
A. Torres-Montaner. (2021) The telomere complex and the origin of the cancer stem cell. Biomarker Research 9:1.
Crossref
David Gajzer, Constantine N. Logothetis, David A. Sallman, Gregoire Calon, Abida Babu, Onyee Chan, Nicole D. Vincelette, Virginia O. Volpe, Najla H. Al Ali, Pukhraz Basra, Chetasi Talati, Andrew T. Kuykendall, Qianxing Mo, Eric Padron, Kendra Sweet, Rami S. Komrokji, Jeffrey E. Lancet, Seongseok Yun & Ling Zhang. (2021) MYC overexpression is associated with an early disease progression from MDS to AML. Leukemia Research 111, pages 106733.
Crossref
Hao Chen, Jiewei Wang, Huan Wang, Jingru Liang, Jinhua Dong, Houqiao Bai & Guosheng Jiang. (2021) Advances in the application of Let‑7 microRNAs in the diagnosis, treatment and prognosis of leukemia (Review). Oncology Letters 23:1.
Crossref
Doudou Tang, Yujiao Luo, Yafeng Jiang, Piao Hu, Hongling Peng, Shangjie Wu, Guangsen Zhang & Yewei Wang. (2021) LncRNA KCNQ1OT1 activated by c-Myc promotes cell proliferation via interacting with FUS to stabilize MAP3K1 in acute promyelocytic leukemia. Cell Death & Disease 12:9.
Crossref
Seyed Esmaeil Ahmadi, Samira Rahimi, Bahman Zarandi, Rouzbeh Chegeni & Majid Safa. (2021) MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies. Journal of Hematology & Oncology 14:1.
Crossref
Seongseok Yun, Nicole D. Vincelette, Xiaoqing Yu, Gregory W. Watson, Mario R. Fernandez, Chunying Yang, Taro Hitosugi, Chia-Ho Cheng, Audrey R. Freischel, Ling Zhang, Weimin Li, Hsinan Hou, Franz X. Schaub, Alexis R. Vedder, Ling Cen, Kathy L. McGraw, Jungwon Moon, Daniel J. Murphy, Andrea Ballabio, Scott H. Kaufmann, Anders E. Berglund & John L. Cleveland. (2021) TFEB Links MYC Signaling to Epigenetic Control of Myeloid Differentiation and Acute Myeloid Leukemia. Blood Cancer Discovery 2:2, pages 162-185.
Crossref
Yifeng Dai, Zhiheng Cheng, Doerte R. Fricke, Hongyou Zhao, Wenhui Huang, Qingfu Zhong, Pei Zhu, Wenjuan Zhang, Zhihua Wu, Qing Lin, Huoyan Zhu, Yan Liu, Tingting Qian, Lin Fu, Longzhen Cui & Tiansheng Zeng. (2021) Prognostic role of Wnt and Fzd gene families in acute myeloid leukaemia. Journal of Cellular and Molecular Medicine 25:3, pages 1456-1467.
Crossref
Michal Caspi, Amnon Wittenstein, Michal Kazelnik, Yarden Shor-Nareznoy & Rina Rosin-Arbesfeld. (2021) Therapeutic targeting of the oncogenic Wnt signaling pathway for treating colorectal cancer and other colonic disorders. Advanced Drug Delivery Reviews 169, pages 118-136.
Crossref
Haley E. Ramsey, Dalton Greenwood, Susu Zhang, Merrida Childress, Maria P. Arrate, Agnieszka E. Gorska, Londa Fuller, Yue Zhao, Kristy Stengel, Melissa A. Fischer, Matthew C. Stubbs, Phillip C.C. Liu, Kelli Boyd, Jeffrey C. Rathmell, Scott W. Hiebert & Michael R. Savona. (2021) BET Inhibition Enhances the Antileukemic Activity of Low-dose Venetoclax in Acute Myeloid Leukemia. Clinical Cancer Research 27:2, pages 598-607.
Crossref
Ajit Kumar Rai & Neeraj Kumar Satija. 2021. Translational Biotechnology. Translational Biotechnology 107 133 .
Michela Frenquelli & Giovanni Tonon. (2020) WNT Signaling in Hematological Malignancies. Frontiers in Oncology 10.
Crossref
Botheina Ahmed Thabet Farweez, Nahela Ahmed Shalaby, Doaa Ahmed Gamal Eissa, Raghda El Sayed Abdel Monem Galal, Nashwa El-khazragy & Shaimaa Abdelmalik Pessar. (2020) Lymphoid enhancer-binding factor 1 (LEF-1): a favorable prognostic factor in adult acute myeloid leukemia in Egyptian patients. Egyptian Journal of Medical Human Genetics 21:1.
Crossref
Han Xiao, Simin Liang & Li Wang. (2020) Competing endogenous RNA regulation in hematologic malignancies. Clinica Chimica Acta 509, pages 108-116.
Crossref
Sheila C Soares-Lima, Maria S Pombo-de-Oliveira & Flávia R G Carneiro. (2020) The multiple ways Wnt signaling contributes to acute leukemia pathogenesis. Journal of Leukocyte Biology 108:4, pages 1081-1099.
Crossref
Xin Zhao, Peng Shao, Kexin Gai, Fengyin Li, Qiang Shan & Hai-Hui Xue. (2020) β-catenin and γ-catenin are dispensable for T lymphocytes and AML leukemic stem cells. eLife 9.
Crossref
Marina Mastelaro de Rezende, Giselle Zenker Justo, Edgar Julian Paredes-Gamero & Reinoud Gosens. (2020) Wnt-5A/B Signaling in Hematopoiesis throughout Life. Cells 9:8, pages 1801.
Crossref
Joseph A. Clara, Cecilia Monge, Yingzi Yang & Naoko Takebe. (2019) Targeting signalling pathways and the immune microenvironment of cancer stem cells — a clinical update. Nature Reviews Clinical Oncology 17:4, pages 204-232.
Crossref
Anna Bigas, Yolanda Guillén, Leonie Schoch & David Arambilet. (2019) Revisiting β‐Catenin Signaling in T‐Cell Development and T‐Cell Acute Lymphoblastic Leukemia. BioEssays 42:2, pages 1900099.
Crossref
Morteza Ghandadi, Reza Valadan, Hamidreza Mohammadi, Javad Akhtari, Shabanali Khodashenas & Sorour Ashari. (2019) Wnt-β-catenin Signaling Pathway, the Achilles' Heels of Cancer Multidrug Resistance. Current Pharmaceutical Design 25:39, pages 4192-4207.
Crossref
Alessandro Beghini. (2019) Core Binding Factor Leukemia: Chromatin Remodeling Moves Towards Oncogenic Transcription. Cancers 11:12, pages 1973.
Crossref
Bhuwan Giri, Vineet K. Gupta, Brianna Yaffe, Shrey Modi, Pooja Roy, Vrishketan Sethi, Shweta P. Lavania, Selwyn M. Vickers, Vikas Dudeja, Sulagna Banerjee, Justin Watts & Ashok Saluja. (2019) Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia. Journal of Translational Medicine 17:1.
Crossref
Justin J. Montoya, Megan A. Turnidge, Daniel H. Wai, Apurvi R. Patel, David W. Lee, Vijay Gokhale, Laurence H. Hurley, Robert J. Arceci, Cynthia Wetmore & David O. Azorsa. (2019) In vitro activity of a G-quadruplex-stabilizing small molecule that synergizes with Navitoclax to induce cytotoxicity in acute myeloid leukemia cells. BMC Cancer 19:1.
Crossref
Nithya Mudgapalli, Palanisamy Nallasamy, Haritha Chava, Srinivas Chava, Anup S. Pathania, Venugopal Gunda, Santhi Gorantla, Manoj K. Pandey, Subash C. Gupta & Kishore B. Challagundla. (2019) The role of exosomes and MYC in therapy resistance of acute myeloid leukemia: Challenges and opportunities. Molecular Aspects of Medicine 70, pages 21-32.
Crossref
Alicja M. Gruszka, Debora Valli & Myriam Alcalay. (2019) Wnt Signalling in Acute Myeloid Leukaemia. Cells 8:11, pages 1403.
Crossref
Haseeb, Pirzada, Ain & Choi. (2019) Wnt Signaling in the Regulation of Immune Cell and Cancer Therapeutics. Cells 8:11, pages 1380.
Crossref
Nashwa El-Khazragy, Wael Elayat, Safa Matbouly, Sarah Seliman, Ashraqat Sami, Gehan Safwat & Ayman Diab. (2019) The prognostic significance of the long non-coding RNAs “CCAT1, PVT1” in t(8;21) associated Acute Myeloid Leukemia. Gene 707, pages 172-177.
Crossref
Tapas Bhadra, Saurav Mallik & Sanghamitra Bandyopadhyay. (2019) Identification of Multiview Gene Modules Using Mutual Information-Based Hypograph Mining. IEEE Transactions on Systems, Man, and Cybernetics: Systems 49:6, pages 1119-1130.
Crossref
Guodong Liu, Shan Liu, Guanyi Cao, Weihuan Luo, Peng Li, Shiping Wang & Yu Chen. (2019) SPAG5 contributes to the progression of gastric cancer by upregulation of Survivin depend on activating the wnt/β-catenin pathway. Experimental Cell Research 379:1, pages 83-91.
Crossref
Ann-Kathrin Häfner, Astrid S. Kahnt & Dieter Steinhilber. (2019) Beyond leukotriene formation—The noncanonical functions of 5-lipoxygenase. Prostaglandins & Other Lipid Mediators 142, pages 24-32.
Crossref
Sharmistha Chatterjee & Parames C. Sil. (2019) Targeting the crosstalks of Wnt pathway with Hedgehog and Notch for cancer therapy. Pharmacological Research 142, pages 251-261.
Crossref
Noemie Luong-Gardiol, Imran Siddiqui, Irene Pizzitola, Beena Jeevan-Raj, Mélanie Charmoy, Yun Huang, Anja Irmisch, Sara Curtet, Georgi S. Angelov, Maxime Danilo, Mélanie Juilland, Beat Bornhauser, Margot Thome, Oliver Hantschel, Yves Chalandon, Gianni Cazzaniga, Jean-Pierre Bourquin, Joerg Huelsken & Werner Held. (2019) γ-Catenin-Dependent Signals Maintain BCR-ABL1+ B Cell Acute Lymphoblastic Leukemia. Cancer Cell 35:4, pages 649-663.e10.
Crossref
Guilin Tang, Shimin Hu, Sa A. Wang, Wei Xie, Pei Lin, Jie Xu, Gokce Toruner, Ming Zhao, Jun Gu, Madison Doty, Shaoying Li, L. Jeffrey Medeiros & Zhenya Tang. (2019) t(3;8)(q26.2;q24) Often Leads to MECOM/MYC Rearrangement and Is Commonly Associated with Therapy-Related Myeloid Neoplasms and/or Disease Progression. The Journal of Molecular Diagnostics 21:2, pages 343-351.
Crossref
Phyllis S. Y. Chong, Jianbiao Zhou, Jing-Yuan Chooi, Zit-Liang Chan, Sabrina Hui Min Toh, Tuan Zea Tan, Sheena Wee, Jayantha Gunaratne, Qi Zeng & Wee-Joo Chng. (2018) Non-canonical activation of β-catenin by PRL-3 phosphatase in acute myeloid leukemia. Oncogene 38:9, pages 1508-1519.
Crossref
T. I. Fetisov, E. A. Lesovaya, M. G. Yakubovskaya, K. I. Kirsanov & G. A. Belitsky. (2019) Alterations in WNT Signaling in Leukemias. Biochemistry (Moscow) 83:12-13, pages 1448-1458.
Crossref
Saeed Mohammadi, Mahdi Zahedpanah, Seyed Hamidollah Ghaffari, Mojgan Shaiegan, Mohsen Nikbakht, Mahin Nikugoftar, Babak Rahmani & Dariush Hamedi Asl. (2018) Evaluation of the Gene Expression of the Cytoprotective Proteins in Response to Daunorubicin in U937 Cells. International Journal of Cancer Management In Press:In Press.
Crossref
Can Chen, Xilian Huang, Kaile Wang, Kuang Chen, Danquan Gao & Shenxian Qian. (2018) Early mortality in acute promyelocytic leukemia: Potential predictors (Review). Oncology Letters.
Crossref
William Grey, Adam Ivey, Thomas A. Milne, Torsten Haferlach, David Grimwade, Frank Uhlmann, Edwige Voisset & Veronica Yu. (2018) The Cks1/Cks2 axis fine-tunes Mll1 expression and is crucial for MLL-rearranged leukaemia cell viability. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1865:1, pages 105-116.
Crossref
Stephanie Grainger, David Traver & Karl Willert. 2018. WNT Signaling in Health and Disease. WNT Signaling in Health and Disease 321 341 .
George P. Studzinski, Elzbieta Gocek, Frederick Coffman & Michael Danilenko. 2018. Vitamin D. Vitamin D 761 799 .
Peter H. Wiernik, Robert E. Gallagher & Martin S. Tallman. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 409 463 .
Markus Schick, Stefan Habringer, Jonas A. Nilsson & Ulrich Keller. (2017) Pathogenesis and therapeutic targeting of aberrant MYC expression in haematological cancers. British Journal of Haematology 179:5, pages 724-738.
Crossref
Muhammad Kashif Mughal, Ariz Akhter, Lesley Street, Payam Pournazari, Meer-Taher Shabani-Rad & Adnan Mansoor. (2017) Acute myeloid leukaemia: expression of MYC protein and its association with cytogenetic risk profile and overall survival. Hematological Oncology 35:3, pages 350-356.
Crossref
Mona Khalaj & Christopher Y. Park. (2017) snoRNAs contribute to myeloid leukaemogenesis. Nature Cell Biology 19:7, pages 758-760.
Crossref
Fengbiao Zhou, Yi Liu, Christian Rohde, Cornelius Pauli, Dennis Gerloff, Marcel Köhn, Danny Misiak, Nicole Bäumer, Chunhong Cui, Stefanie Göllner, Thomas Oellerich, Hubert Serve, Maria-Paz Garcia-Cuellar, Robert Slany, Jaroslaw P. Maciejewski, Bartlomiej Przychodzen, Barbara Seliger, Hans-Ulrich Klein, Christoph Bartenhagen, Wolfgang E. Berdel, Martin Dugas, Makoto Mark Taketo, Daneyal Farouq, Schraga Schwartz, Aviv Regev, Josée Hébert, Guy Sauvageau, Caroline Pabst, Stefan Hüttelmaier & Carsten Müller-Tidow. (2017) AML1-ETO requires enhanced C/D box snoRNA/RNP formation to induce self-renewal and leukaemia. Nature Cell Biology 19:7, pages 844-855.
Crossref
Dong Min Kim, Hanbit Jang, Myung Geun Shin, Jeong-Hoon Kim, Sang Mo Shin, Sang-Hyun Min & Il-Chul Kim. (2017) β-catenin induces expression of prohibitin gene in acute leukemic cells. Oncology Reports 37:6, pages 3201-3208.
Crossref
Zackie Aktary, Mahsa Alaee & Manijeh Pasdar. (2017) Beyond cell-cell adhesion: Plakoglobin and the regulation of tumorigenesis and metastasis. Oncotarget 8:19, pages 32270-32291.
Crossref
T Zhan, N Rindtorff & M Boutros. (2016) Wnt signaling in cancer. Oncogene 36:11, pages 1461-1473.
Crossref
Kran Suknuntha, Thanyatip Thita, Padma Priya Togarrati, Piyanee Ratanachamnong, Patompon Wongtrakoongate, Sirada Srihirun, Igor Slukvin & Suradej Hongeng. (2016) Wnt signaling inhibitor FH535 selectively inhibits cell proliferation and potentiates imatinib-induced apoptosis in myeloid leukemia cell lines. International Journal of Hematology 105:2, pages 196-205.
Crossref
S Weng, S Matsuura, C T Mowery, S A Stoner, K Lam, D Ran, A G Davis, M-C Lo & D-E Zhang. (2016) Restoration of MYC-repressed targets mediates the negative effects of GM-CSF on RUNX1-ETO leukemogenicity. Leukemia 31:1, pages 159-169.
Crossref
Shan Lin, James C. Mulloy & Susumu Goyama. 2017. RUNX Proteins in Development and Cancer. RUNX Proteins in Development and Cancer 151 173 .
Ana Podolski-Renić, Zorica Milošević, Jelena Dinić, Tijana Stanković, Jasna Banković & Milica Pešić. (2016) Mutual regulation and targeting of multidrug resistance and cancer stem phenotype. MedChemComm 7:12, pages 2265-2281.
Crossref
Rui Su, Jia-Nan Gong, Ming-Tai Chen, Li Song, Chao Shen, Xin-Hua Zhang, Xiao-Lin Yin, Hong-Mei Ning, Bing Liu, Fang Wang, Yan-Ni Ma, Hua-Lu Zhao, Jia Yu & Jun-Wu Zhang. (2016) c-Myc suppresses miR-451⊣YWTAZ/AKT axis via recruiting HDAC3 in acute myeloid leukemia. Oncotarget 7:47, pages 77430-77443.
Crossref
Rudolph Willis. (2016) Targeted Cancer Therapy: Vital Oncogenes and a New Molecular Genetic Paradigm for Cancer Initiation Progression and Treatment. International Journal of Molecular Sciences 17:9, pages 1552.
Crossref
Thomas H. Shin, Christopher Brynczka, Farshid Dayyani, Miguel N. Rivera & David A. Sweetser. (2016) TLE4 regulation of wnt-mediated inflammation underlies its role as a tumor suppressor in myeloid leukemia. Leukemia Research 48, pages 46-56.
Crossref
Ye Ding, Ze-chuan Wang, Yi Zheng, Zheng Hu, Yang Li, Dong-feng Luo & Shao-yuan Wang. (2016) C-Myc functions as a competing endogenous RNA in acute promyelocytic leukemia. Oncotarget 7:35, pages 56422-56430.
Crossref
Frank Staal, Farbod Famili, Laura Garcia Perez & Karin Pike-Overzet. (2016) Aberrant Wnt Signaling in Leukemia. Cancers 8:9, pages 78.
Crossref
Jian Li, Chun Guo, Nickolas Steinauer & Jinsong Zhang. (2016) New insights into transcriptional and leukemogenic mechanisms of AML1-ETO and E2A fusion proteins. Frontiers in Biology 11:4, pages 285-304.
Crossref
Ram Babu Undi, Usha Gutti, Itishri Sahu, Shilpa Sarvothaman, Satya Ratan Pasupuleti, Ravinder Kandi & Ravi Kumar Gutti. (2015) Wnt Signaling: Role in Regulation of Haematopoiesis. Indian Journal of Hematology and Blood Transfusion 32:2, pages 123-134.
Crossref
Jessica Roos, Sabine Grösch, Oliver Werz, Peter Schröder, Slava Ziegler, Simone Fulda, Patrick Paulus, Anja Urbschat, Benjamin Kühn, Isabelle Maucher, Jasmin Fettel, Thomas Vorup-Jensen, Matthias Piesche, Carmela Matrone, Dieter Steinhilber, Michael J. Parnham & Thorsten J. Maier. (2016) Regulation of tumorigenic Wnt signaling by cyclooxygenase-2, 5-lipoxygenase and their pharmacological inhibitors: A basis for novel drugs targeting cancer cells?. Pharmacology & Therapeutics 157, pages 43-64.
Crossref
Atsushi Hirao, Yuko Tadokoro & Masaya Ueno. 2016. Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia. Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia 11 28 .
Zheng Ge, Xing Guo, Jianyong Li, Melanie Hartman, Yuka Imamura Kawasawa, Sinisa Dovat & Chunhua Song. (2015) Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia . Oncotarget 6:39, pages 42300-42311.
Crossref
K Kühn, C Cott, S Bohler, S Aigal, S Zheng, S Villringer, A Imberty, J Claudinon & W Römer. (2015) The interplay of autophagy and β-Catenin signaling regulates differentiation in acute myeloid leukemia. Cell Death Discovery 1:1.
Crossref
Ashley PandolfiRobert F. StanleyYiting YuBoris BartholdyGopichand PendurtiKira GritsmanJacqueline Boultwood, Jonathan Chernoff, Amit VermaUlrich Steidl. (2015) PAK1 is a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome. Blood 126:9, pages 1118-1127.
Crossref
Lan Wang, Na Man, Xiao-Jian SunYurong Tan, Marta García-Cao, Fan Liu, Megan HatlenHaiming XuGang Huang, Meredith MattlinArpit Mehta, Evadnie Rampersaud, Robert Benezra & Stephen D. Nimer. (2015) Regulation of AKT signaling by Id1 controls t(8;21) leukemia initiation and progression. Blood 126:5, pages 640-650.
Crossref
Eishi Ashihara, Tetsuya Takada & Taira Maekawa. (2015) Targeting the canonical Wnt/β‐catenin pathway in hematological malignancies. Cancer Science 106:6, pages 665-671.
Crossref
Andrea KühnlPeter J. M. ValkMathijs A. SandersAdam IveyRobert K. HillsKen I. MillsRosemary E. GaleMartin F. KaiserRichard DillonMelanie JoannidesAmanda GilkesTorsten Haferlach, Susanne Schnittger, Estelle Duprez, David C. LinchRuud DelwelBob LöwenbergClaudia D. BaldusEllen SolomonAlan K. BurnettDavid Grimwade. (2015) Downregulation of the Wnt inhibitor CXXC5 predicts a better prognosis in acute myeloid leukemia. Blood 125:19, pages 2985-2994.
Crossref
Anahita Rafiei, Afsar Ali Mian, Claudia Döring, Anna Metodieva, Claudia Oancea, Frederic B. Thalheimer, Martin Leo Hansmann, Oliver Gerhard Ottmann & Martin Ruthardt. (2015) The Functional Interplay Between the t(9;22)-Associated Fusion Proteins BCR/ABL and ABL/BCR in Philadelphia Chromosome-Positive Acute Lymphatic Leukemia. PLOS Genetics 11:4, pages e1005144.
Crossref
R. Allan Mufson. 2006. Reviews in Cell Biology and Molecular Medicine. Reviews in Cell Biology and Molecular Medicine 140 163 .
Smita Dandekar, Eleny Romanos-Sirakis, Faye Pais, Teena Bhatla, Courtney Jones, Wallace Bourgeois, Stephen P. Hunger, Elizabeth A. Raetz, Michelle L. Hermiston, Ramanuj Dasgupta, Debra J. Morrison & William L. Carroll. (2014) Wnt inhibition leads to improved chemosensitivity in paediatric acute lymphoblastic leukaemia. British Journal of Haematology 167:1, pages 87-99.
Crossref
Jessica Roos, Claudia Oancea, Maria Heinssmann, Dilawar Khan, Hannelore Held, Astrid S. Kahnt, Ricardo Capelo, Estel la Buscató, Ewgenij Proschak, Elena Puccetti, Dieter Steinhilber, Ingrid Fleming, Thorsten J. Maier & Martin Ruthardt. (2014) 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia. Cancer Research 74:18, pages 5244-5255.
Crossref
Diwakar R. PattabiramanCrystal McGirr, Konstantin ShakhbazovValerie BarbierKeerthana Krishnan, Pamela MukhopadhyayPaula HawthorneAnn TreziseJianmin Ding, Sean M. Grimmond, Peter Papathanasiou, Warren S. Alexander, Andrew C. Perkins, Jean-Pierre LevesqueIngrid G. WinklerThomas J. Gonda. (2014) Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes. Blood 123:17, pages 2682-2690.
Crossref
Francesco Albano, Antonella Zagaria, Luisa Anelli, Paola Orsini, Crescenzio Francesco Minervini, Luciana Impera, Paola Casieri, Nicoletta Coccaro, Giuseppina Tota, Claudia Brunetti, Angela Minervini, Domenico Pastore, Paola Carluccio, Anna Mestice, Angelo Cellamare & Giorgina Specchia. (2013) Lymphoid enhancer binding factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia. Oncotarget 5:3, pages 649-658.
Crossref
Miriam Sonnet, Rainer Claus, Natalia Becker, Manuela Zucknick, Jana Petersen, Daniel B Lipka, Christopher C Oakes, Mindaugas Andrulis, Amelie Lier, Michael D Milsom, Tania Witte, Lei Gu, Soo-Zin Kim-Wanner, Peter Schirmacher, Michael Wulfert, Norbert Gattermann, Michael Lübbert, Frank Rosenbauer, Michael Rehli, Lars Bullinger, Dieter Weichenhan & Christoph Plass. (2014) Early aberrant DNA methylation events in a mouse model of acute myeloid leukemia. Genome Medicine 6:4, pages 34.
Crossref
Anna Eriksson, Antonia Kalushkova, Malin Jarvius, Riet Hilhorst, Linda Rickardson, Hanna Göransson Kultima, Rik de Wijn, Liesbeth Hovestad, Mårten Fryknäs, Fredrik Öberg, Rolf Larsson, Vendela Parrow & Martin Höglund. (2014) AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and dose dependent reduction of tyrosine kinase activity in acute myeloid leukemia. Biochemical Pharmacology 87:2, pages 284-291.
Crossref
Ainara Soria, Jacobo Muñoz del Toro, Raquel Fuentes & Alfonso Cortés. 2014. Stem Cells in Cancer: Should We Believe or Not?. Stem Cells in Cancer: Should We Believe or Not? 203 228 .
Kim L. Rice, Monica Buzzai, Jessica Altman & Jonathan D. Licht. 2015. Molecular Oncology. Molecular Oncology 751 768 .
Machteld M Tiemessen & Frank JT Staal. (2013) Wnt signaling in leukemias and myeloma: T-cell factors are in control. Future Oncology 9:11, pages 1757-1772.
Crossref
Marina Scheller, Jörg Schönheit, Karin Zimmermann, Ulf Leser, Frank Rosenbauer & Achim Leutz. (2013) Cross talk between Wnt/β-catenin and Irf8 in leukemia progression and drug resistance . Journal of Experimental Medicine 210:11, pages 2239-2256.
Crossref
G Ma, J Yasunaga, J Fan, S Yanagawa & M Matsuoka. (2012) HTLV-1 bZIP factor dysregulates the Wnt pathways to support proliferation and migration of adult T-cell leukemia cells. Oncogene 32:36, pages 4222-4230.
Crossref
Alicja Gruszka & Myriam Alcalay. 2013. Handbook of Therapeutic Biomarkers in Cancer. Handbook of Therapeutic Biomarkers in Cancer 313 336 .
Yiyun ZhangJianfeng WangJustin WheatXi ChenShan JinHossein SadrzadehAmir T. FathiRandall T. Peterson, Andrew L. Kung, David A. SweetserJing-Ruey Joanna Yeh. (2013) AML1-ETO mediates hematopoietic self-renewal and leukemogenesis through a COX/β-catenin signaling pathway. Blood 121:24, pages 4906-4916.
Crossref
Claudio Cantù, Tomas Valenta, George Hausmann, Nathalie Vilain, Michel Aguet & Konrad Basler. (2013) The Pygo2-H3K4me2/3 interaction is dispensable for mouse development and Wnt signaling-dependent transcription. Development 140:11, pages 2377-2386.
Crossref
CHANG-CHUN NIU, CHEN ZHAO, ZHEN-DONG YANG, XIAO-LI ZHANG, WEI-RU WU, JING PAN, CHEN ZHAO, ZHI-QIANG LI, WEI DING, ZHONG YANG & WEI-KE SI. (2013) Downregulation of γ-catenin inhibits CML cell growth and potentiates the response of CML cells to imatinib through β-catenin inhibition. International Journal of Molecular Medicine 31:2, pages 453-458.
Crossref
R G Morgan, L Pearn, K Liddiard, S L Pumford, A K Burnett, A Tonks & R L Darley. (2012) γ-Catenin is overexpressed in acute myeloid leukemia and promotes the stabilization and nuclear localization of β-catenin. Leukemia 27:2, pages 336-343.
Crossref
M. Dolores Delgado, Marta Albajar, M. Teresa Gomez-Casares, Ana Batlle & Javier León. (2012) MYC oncogene in myeloid neoplasias. Clinical and Translational Oncology 15:2, pages 87-94.
Crossref
Peter H. Wiernik, Robert E. Gallagher & Martin S. Tallman. 2013. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 403 453 .
Richard G. James, Kathryn C. Davidson, Katherine A. Bosch, Travis L. Biechele, Nicholas C. Robin, Russell J. Taylor, Michael B. Major, Nathan D. Camp, Kerry Fowler, Timothy J. Martins & Randall T. Moon. (2012) WIKI4, a Novel Inhibitor of Tankyrase and Wnt/ß-Catenin Signaling. PLoS ONE 7:12, pages e50457.
Crossref
David Swope, Jifen Li, Eliane J. Muller & Glenn L. Radice. (2012) Analysis of a Jup hypomorphic allele reveals a critical threshold for postnatal viability . genesis 50:10, pages 717-727.
Crossref
Klaus H. MetzelerBernhard HeilmeierKatrin E. EdmaierVijay P. S. RawatAnnika DufourKonstanze DöhnerMichaela Feuring-BuskeJan BraessKarsten SpiekermannThomas BüchnerMaria C. Sauerland, Hartmut DöhnerWolfgang HiddemannStefan K. Bohlander, Richard F. SchlenkLars BullingerChristian Buske. (2012) High expression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in cytogenetically normal acute myeloid leukemia. Blood 120:10, pages 2118-2126.
Crossref
Megan A. Hatlen, Lan Wang & Stephen D. Nimer. (2012) AML1-ETO driven acute leukemia: insights into pathogenesis and potential therapeutic approaches. Frontiers of Medicine 6:3, pages 248-262.
Crossref
S P Boudreaux, A M Ramirez-Herrick, R P Duren & O M Conneely. (2012) Genome-wide profiling reveals transcriptional repression of MYC as a core component of NR4A tumor suppression in acute myeloid leukemia. Oncogenesis 1:7, pages e19-e19.
Crossref
Florian H. Heidel, Lars Bullinger, Zhaohui Feng, Zhu Wang, Tobias A. Neff, Lauren Stein, Demetrios Kalaitzidis, Steven W. Lane & Scott A. Armstrong. (2012) Genetic and Pharmacologic Inhibition of β-Catenin Targets Imatinib-Resistant Leukemia Stem Cells in CML. Cell Stem Cell 10:4, pages 412-424.
Crossref
Yan Yang, Qing Huang, Yanjun Lu, Xiaoqing Li & Shiang Huang. (2012) Reactivating PP2A by FTY720 as a Novel therapy for AML with C-KIT tyrosine kinase domain mutation. Journal of Cellular Biochemistry 113:4, pages 1314-1322.
Crossref
T C Luis, M Ichii, M H Brugman, P Kincade & F J T Staal. (2011) Wnt signaling strength regulates normal hematopoiesis and its deregulation is involved in leukemia development. Leukemia 26:3, pages 414-421.
Crossref
Kari Högstrand, Eduar Hejll, Birgitta Sander, Björn Rozell, Lars-Gunnar Larsson & Alf Grandien. (2012) Inhibition of the Intrinsic but Not the Extrinsic Apoptosis Pathway Accelerates and Drives Myc-Driven Tumorigenesis Towards Acute Myeloid Leukemia. PLoS ONE 7:2, pages e31366.
Crossref
Vu Duong & Jeffrey Lancet. 2012. Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics. Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics 315 348 .
Chi Keung ChengLibby LiSuk Hang ChengKitty NgNatalie P. H. ChanRosalina K. L. IpRaymond S. M. Wong, Matthew M. K. Shing, Chi Kong Li & Margaret H. L. Ng. (2011) Secreted-frizzled related protein 1 is a transcriptional repression target of the t(8;21) fusion protein in acute myeloid leukemia. Blood 118:25, pages 6638-6648.
Crossref
Andrea KühnlNicola GökbugetMartin KaiserCornelia SchleeAndrea Stroux, Thomas BurmeisterLiliana H. MochmannDieter HoelzerWolf-Karsten Hofmann, Eckhard ThielClaudia D. Baldus. (2011) Overexpression of LEF1 predicts unfavorable outcome in adult patients with B-precursor acute lymphoblastic leukemia. Blood 118:24, pages 6362-6367.
Crossref
H-A Hou, Y-Y Kuo, C-Y Liu, M C Lee, J-L Tang, C-Y Chen, W-C Chou, C-F Huang, F-Y Lee, M-C Liu, M Yao & H-F Tien. (2011) Distinct association between aberrant methylation of Wnt inhibitors and genetic alterations in acute myeloid leukaemia. British Journal of Cancer 105:12, pages 1927-1933.
Crossref
Elisabeth Ersvaer, Kimberley J. Hatfield, Håkon Reikvam & Øystein Bruserud. (2011) Future Perspectives: Therapeutic Targeting of Notch Signalling May Become a Strategy in Patients Receiving Stem Cell Transplantation for Hematologic Malignancies. Bone Marrow Research 2011, pages 1-15.
Crossref
Antonio Porro, Nunzio Iraci, Simona Soverini, Daniel Diolaiti, Samuele Gherardi, Carolina Terragna, Sandra Durante, Emanuele Valli, Thea Kalebic, Roberto Bernardoni, Chiara Perrod, Michelle Haber, Murray D. Norris, Michele Baccarani, Giovanni Martinelli & Giovanni Perini. (2011) c-MYC Oncoprotein Dictates Transcriptional Profiles of ATP-Binding Cassette Transporter Genes in Chronic Myelogenous Leukemia CD34+ Hematopoietic Progenitor Cells. Molecular Cancer Research 9:8, pages 1054-1066.
Crossref
Zhi-yi Guo, Xiao-hui Hao, Fei-Fei Tan, Xin Pei, Li-Mei Shang, Xue-lian Jiang & Fang Yang. (2011) The elements of human cyclin D1 promoter and regulation involved. Clinical Epigenetics 2:2, pages 63-76.
Crossref
Susumu Goyama & James C. Mulloy. (2011) Molecular pathogenesis of core binding factor leukemia: current knowledge and future prospects. International Journal of Hematology 94:2, pages 126-133.
Crossref
Gunnar Steinert, Claudia Oancea, Jessica Roos, Heike Hagemeyer, Thorsten Maier, Martin Ruthardt & Elena Puccetti. (2011) Sulindac Sulfide Reverses Aberrant Self-Renewal of Progenitor Cells Induced by the AML-Associated Fusion Proteins PML/RARα and PLZF/RARα. PLoS ONE 6:7, pages e22540.
Crossref
Sung Wook Seo, Hyewon Lee, Hyun-Il Lee & Han-Soo Kim. (2011) The role of TLE1 in synovial sarcoma. Journal of Orthopaedic Research 29:7, pages 1131-1136.
Crossref
Mariela SivinaTakeshi YamadaChun Shik ParkMonica PuppiSuleyman CoskunKaren HirschiH. Daniel Lacorazza. (2011) The Transcription Factor E74-Like Factor Controls Quiescence of Endothelial Cells and Their Resistance to Myeloablative Treatments in Bone Marrow. Arteriosclerosis, Thrombosis, and Vascular Biology 31:5, pages 1185-1191.
Crossref
A Gandillet, S Park, F Lassailly, E Griessinger, J Vargaftig, A Filby, T A Lister & D Bonnet. (2011) Heterogeneous sensitivity of human acute myeloid leukemia to β-catenin down-modulation. Leukemia 25:5, pages 770-780.
Crossref
Lara Tickenbrock, Hans-Ulrich Klein, Cristina Trento, Antje Hascher, Stefanie Göllner, Nicole Bäumer, Robert Kuss, Shuchi Agrawal, Gesine Bug, Hubert Serve, Christian Thiede, Gerhard Ehninger, Udo zur Stadt, Michael McClelland, Yipeng Wang, Anke Becker, Steffen Koschmieder, Wolfgang E. Berdel, Martin Dugas & Carsten Müller-Tidow. (2011) Increased HDAC1 deposition at hematopoietic promoters in AML and its association with patient survival. Leukemia Research 35:5, pages 620-625.
Crossref
Björn SteffenMarkus KnopUlla BergholzOlesya VakhrushevaMiriam RodeGabriele KöhlerMarcel-Philipp HenrichsEtmar BulkSina HehnMartin StehlingMartin Dugas, Nicole BäumerPetra TschanterChristian BrandtsSteffen Koschmieder, Wolfgang E. BerdelHubert ServeCarol StockingCarsten Müller-Tidow. (2011) AML1/ETO induces self-renewal in hematopoietic progenitor cells via the Groucho-related amino-terminal AES protein. Blood 117:16, pages 4328-4337.
Crossref
Naoko Takebe, Pamela J. Harris, Ronald Q. Warren & S. Percy Ivy. (2010) Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nature Reviews Clinical Oncology 8:2, pages 97-106.
Crossref
Elena K. Siapati, Magda Papadaki, Zoi Kozaou, Erasmia Rouka, Evridiki Michali, Ioanna Savvidou, Dimitrios Gogos, Despina Kyriakou, Nikos I. Anagnostopoulos & George Vassilopoulos. (2011) Proliferation and bone marrow engraftment of AML blasts is dependent on β-catenin signalling. British Journal of Haematology 152:2, pages 164-174.
Crossref
I. Uribesalgo & L. Di Croce. (2011) Dynamics of epigenetic modifications in leukemia. Briefings in Functional Genomics 10:1, pages 18-29.
Crossref
Olga Gaidarenko & Yang Xu. 2011. Cancer Stem Cells in Solid Tumors. Cancer Stem Cells in Solid Tumors 209 222 .
Markus Müschen. 2011. Targeting the Wnt Pathway in Cancer. Targeting the Wnt Pathway in Cancer 129 142 .
A Gessner, M Thomas, P Garrido Castro, L Büchler, A Scholz, T H Brümmendorf, N Martinez Soria, J Vormoor, J Greil & O Heidenreich. (2010) Leukemic fusion genes MLL/AF4 and AML1/MTG8 support leukemic self-renewal by controlling expression of the telomerase subunit TERT. Leukemia 24:10, pages 1751-1759.
Crossref
Ya-Chen Liu, Wei-Chih Lai, Kai-An Chuang, Yu-Jie Shen, Wensi S. Hu, Cheng-Han Ho, Yu-Bei Chen, Min-Fen Hsu, Hui-Chi Hsu & Chien-Hui Lieu. (2010) Blockade of JAK2 activity suppressed accumulation of β-catenin in leukemic cells. Journal of Cellular Biochemistry 111:2, pages 402-411.
Crossref
Mitchell S. Cairo, Craig T. Jordan, Carlo C. Maley, Clifford Chao, Ari Melnick, Scott A. Armstrong, Warren Shlomchik, Jeff Molldrem, Soldano Ferrone, Crystal Mackall, Laurence Zitvogel, Michael R. Bishop, Sergio A. Giralt & Carl H. June. (2010) NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biological Considerations of Hematological Relapse following Allogeneic Stem Cell Transplantation Unrelated to Graft-versus-Tumor Effects: State of the Science. Biology of Blood and Marrow Transplantation 16:6, pages 709-728.
Crossref
Yingzi WangAndrei V. KrivtsovAmit U. SinhaTrista E. NorthWolfram GoesslingZhaohui FengLeonard I. ZonScott A. Armstrong. (2010) The Wnt/β-Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AML. Science 327:5973, pages 1650-1653.
Crossref
Man Mohan, Hans-Martin Herz, Yoh-Hei Takahashi, Chengqi Lin, Ka Chun Lai, Ying Zhang, Michael P. Washburn, Laurence Florens & Ali Shilatifard. (2010) Linking H3K79 trimethylation to Wnt signaling through a novel Dot1-containing complex (DotCom). Genes & Development 24:6, pages 574-589.
Crossref
Jonas Renström, Monika Kröger, Christian Peschel & Robert A.J. Oostendorp. (2010) How the niche regulates hematopoietic stem cells. Chemico-Biological Interactions 184:1-2, pages 7-15.
Crossref
Kim-Hien T. Dao & H. M. Jamieson Catriona. 2010. Hematopoietic Stem Cell Biology. Hematopoietic Stem Cell Biology 213 243 .
Kim L. RiceItsaso HormaecheSergei DoulatovJared M. FlatowDavid GrimwadeKen I. MillsMagdalena LeivaJulien AblainCharuta AmbardekarMelanie J. McConnell, John E. Dick & Jonathan D. Licht. (2009) Comprehensive genomic screens identify a role for PLZF-RARα as a positive regulator of cell proliferation via direct regulation of c-MYC. Blood 114:27, pages 5499-5511.
Crossref
Xiaoyu Cheng & Helen C. O’Neill. (2009) Oncogenesis and cancer stem cells: current opinions and future directions. Journal of Cellular and Molecular Medicine 13:11-12, pages 4377-4384.
Crossref
Iris Gehrke, Rajesh Kumar Gandhirajan & Karl-Anton Kreuzer. (2009) Targeting the WNT/β-catenin/TCF/LEF1 axis in solid and haematological cancers: Multiplicity of therapeutic options. European Journal of Cancer 45:16, pages 2759-2767.
Crossref
A Valencia, J Román-Gómez, J Cervera, E Such, E Barragán, P Bolufer, F Moscardó, G F Sanz & M A Sanz. (2009) Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia. Leukemia 23:9, pages 1658-1666.
Crossref
Pamela M. CorriganEdwina DobbinRobin W. FreeburnHelen Wheadon. (2009) Patterns of Wnt/Fzd/LRP Gene Expression During Embryonic Hematopoiesis. Stem Cells and Development 18:5, pages 759-772.
Crossref
Takeshi Yamada, Chun Shik Park, Maksim Mamonkin & H Daniel Lacorazza. (2009) Transcription factor ELF4 controls the proliferation and homing of CD8+ T cells via the Krüppel-like factors KLF4 and KLF2. Nature Immunology 10:6, pages 618-626.
Crossref
Katharina Salome Minke, Peter Staib, Adriane Puetter, Iris Gehrke, Rajesh Kumar Gandhirajan, Axel Schlösser, Esther Katharina Schmitt, Michael Hallek & Karl-Anton Kreuzer. (2009) Small molecule inhibitors of WNT signaling effectively induce apoptosis in acute myeloid leukemia cells. European Journal of Haematology 82:3, pages 165-175.
Crossref
Marit Kveine Nygren, Guri Døsen-Dahl, Heidi Stubberud, Sébastien Wälchli, Else Munthe & Edith Rian. (2009) β-catenin is involved in N-cadherin–dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1–positive B acute lymphoblastic leukemia cells. Experimental Hematology 37:2, pages 225-233.
Crossref
Chih-Cheng Chen, Jyh-Pyng Gau, Jie-Yu You, Kuan-Der Lee, Yuan-Bin Yu, Chang-Hsien Lu, Jen-Tsun Lin, Chieh Lan, Wan-Hsia Lo, Jacqueline Ming Liu & Ching-Fen Yang. (2009) Prognostic significance of β-catenin and topoisomerase IIα in de novo acute myeloid leukemia. American Journal of Hematology 84:2, pages 87-92.
Crossref
Ming YanEun-Young AhnScott W. Hiebert & Dong-Er Zhang. (2009) RUNX1/AML1 DNA-binding domain and ETO/MTG8 NHR2-dimerization domain are critical to AML1-ETO9a leukemogenesis. Blood 113:4, pages 883-886.
Crossref
Rashmi S. GoswamiMahadeo A. SukhaiMariam ThomasPatricia P. ReisSuzanne Kamel-Reid. (2008) Applications of Microarray Technology to Acute Myelogenous Leukemia. Cancer Informatics 7, pages CIN.S1015.
Crossref
Ilaria Malanchi & Joerg Huelsken. (2009) Cancer stem cells: never Wnt away from the niche. Current Opinion in Oncology 21:1, pages 41-46.
Crossref
Dominique Bonnet. 2009. Regulatory Networks in Stem Cells. Regulatory Networks in Stem Cells 519 526 .
Mhairi Copland, Alison M. Michie & Tessa L. Holyoake. 2009. Stem Cells and Cancer. Stem Cells and Cancer 111 136 .
Dominique Bonnet. 2009. Molecular Basis of Hematopoiesis. Molecular Basis of Hematopoiesis 215 230 .
Anthony J. Robertson, Alison Coluccio, Peter Knowlton, Carrie Dickey-Sims & James A. Coffman. (2008) Runx Expression Is Mitogenic and Mutually Linked to Wnt Activity in Blastula-Stage Sea Urchin Embryos. PLoS ONE 3:11, pages e3770.
Crossref
Devrim Acehan, Christopher Petzold, Iwona Gumper, David D. Sabatini, Eliane J. Müller, Pamela Cowin & David L. Stokes. (2008) Plakoglobin Is Required for Effective Intermediate Filament Anchorage to Desmosomes. Journal of Investigative Dermatology 128:11, pages 2665-2675.
Crossref
E. Jost, J. Schmid, S. Wilop, C. Schubert, H. Suzuki, J. G. Herman, R. Osieka & O. Galm. (2008) Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia. British Journal of Haematology 142:5, pages 745-753.
Crossref
Christine Dierks, Ronak Beigi, Gui-Rong Guo, Katja Zirlik, Mario R. Stegert, Paul Manley, Christopher Trussell, Annette Schmitt-Graeff, Klemens Landwerlin, Hendrik Veelken & Markus Warmuth. (2008) Expansion of Bcr-Abl-Positive Leukemic Stem Cells Is Dependent on Hedgehog Pathway Activation. Cancer Cell 14:3, pages 238-249.
Crossref
Lara Tickenbrock, Sina Hehn, Bülent Sargin, Georg Evers, Pavankumar Reddy NG, Chunaram Choudhary, Wolfgang E. Berdel, Carsten Müller-Tidow & Hubert Serve. (2008) Activation of Wnt signaling in cKit-ITD mediated transformation and imatinib sensitivity in acute myeloid leukemia. International Journal of Hematology 88:2, pages 174-180.
Crossref
Michael Lübbert, Carsten Müller-Tidow, Wolf-Karsten Hofmann & H. Phillip Koeffler. (2008) Advances in the treatment of acute myeloid leukemia: From chromosomal aberrations to biologically targeted therapy. Journal of Cellular Biochemistry 104:6, pages 2059-2070.
Crossref
Frank J. T. Staal, Tiago C. Luis & Machteld M. Tiemessen. (2008) WNT signalling in the immune system: WNT is spreading its wings. Nature Reviews Immunology 8:8, pages 581-593.
Crossref
Blazej Dolniak, Efstratios Katsoulidis, Nathalie Carayol, Jessica K. Altman, Amanda J. Redig, Martin S. Tallman, Takeshi Ueda, Rie Watanabe-Fukunaga, Rikiro Fukunaga & Leonidas C. Platanias. (2008) Regulation of Arsenic Trioxide-induced Cellular Responses by Mnk1 and Mnk2. Journal of Biological Chemistry 283:18, pages 12034-12042.
Crossref
Farshid Dayyani, Jianfeng Wang, Jing-Ruey J. YehEun-Young AhnErica Tobey, Dong-Er ZhangIrwin D. Bernstein, Randall T. PetersonDavid A. Sweetser. (2008) Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival. Blood 111:8, pages 4338-4347.
Crossref
Claudia HoemmeAbdul PeerzadaGerhard BehreYipeng Wang, Michael McClelland, Kay Nieselt, Matthias Zschunke, Christine DisselhoffShuchi AgrawalFabienne IskenNicola TidowWolfgang E. BerdelHubert ServeCarsten Müller-Tidow. (2008) Chromatin modifications induced by PML-RARα repress critical targets in leukemogenesis as analyzed by ChIP-Chip. Blood 111:5, pages 2887-2895.
Crossref
Grégoire JeannetMarina Scheller, Léonardo ScarpellinoStéphane Duboux, Noemie GardiolJonathan BackFabien Kuttler, Ilaria Malanchi, Walter Birchmeier, Achim Leutz, Joerg Huelsken & Werner Held. (2008) Long-term, multilineage hematopoiesis occurs in the combined absence of β-catenin and γ-catenin. Blood 111:1, pages 142-149.
Crossref
S Agrawal, S Koschmieder, N Bäumer, N G P Reddy, W E Berdel, C Müller-Tidow & H Serve. (2007) Pim2 complements Flt3 wild-type receptor in hematopoietic progenitor cell transformation. Leukemia 22:1, pages 78-86.
Crossref
Inken Wierstra & Jürgen Alves. 2008. 113 333 .
A Tonks, L Pearn, M Musson, A Gilkes, K I Mills, A K Burnett & R L Darley. (2007) Transcriptional dysregulation mediated by RUNX1-RUNX1T1 in normal human progenitor cells and in acute myeloid leukaemia. Leukemia 21:12, pages 2495-2505.
Crossref
Chen Zhao, Jordan Blum, Alan Chen, Hyog Young Kwon, Seung Hye Jung, J. Michael Cook, Anand Lagoo & Tannishtha Reya. (2007) Loss of β-Catenin Impairs the Renewal of Normal and CML Stem Cells In Vivo. Cancer Cell 12:6, pages 528-541.
Crossref
Alexandra Prowald, Marcus V. Cronauer, Christoph von Klot, Tyark Eilers, Ludwig Rinnab, Thomas Herrmann, Klaus-Dieter Spindler, Mathias Montenarh, Udo Jonas & Martin Burchardt. (2007) Modulation of β-catenin-mediated TCF-signalling in prostate cancer cell lines by wild-type and mutant p53. The Prostate 67:16, pages 1751-1760.
Crossref
J-H Mikesch, B Steffen, W E Berdel, H Serve & C Müller-Tidow. (2007) The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia. Leukemia 21:8, pages 1638-1647.
Crossref
Y Tabe, L Jin, R Contractor, D Gold, P Ruvolo, S Radke, Y Xu, Y Tsutusmi-Ishii, K Miyake, N Miyake, S Kondo, A Ohsaka, I Nagaoka, M Andreeff & M Konopleva. (2007) Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1. Cell Death & Differentiation 14:8, pages 1443-1456.
Crossref
Kamaleldin E. Elagib & Adam N. Goldfarb. (2007) Oncogenic pathways of AML1-ETO in acute myeloid leukemia: Multifaceted manipulation of marrow maturation. Cancer Letters 251:2, pages 179-186.
Crossref
Luke F. Peterson, Ming Yan & Dong-Er Zhang. (2007) The p21Waf1 pathway is involved in blocking leukemogenesis by the t(8;21) fusion protein AML1-ETO. Blood 109:10, pages 4392-4398.
Crossref
Carine Kolly, Antony Zakher, Christian Strauss, Maja M. Suter & Eliane J. Müller. (2007) Keratinocyte transcriptional regulation of the human c-Myc promoter occurs via a novel Lef/Tcf binding element distinct from neoplastic cells. FEBS Letters 581:10, pages 1969-1976.
Crossref
Shuchi AgrawalWolf-Karsten HofmannNicola TidowMathias Ehrich, Dirk van den Boom, Steffen KoschmiederWolfgang E. BerdelHubert ServeCarsten Müller-Tidow. (2007) The C/EBPδ tumor suppressor is silenced by hypermethylation in acute myeloid leukemia. Blood 109:9, pages 3895-3905.
Crossref
José Román-GómezLucia CordeuXabier AgirreAntonio Jiménez-VelascoEdurne San José-EnerizLeire GarateMaría José Calasanz, Anabel HeinigerAntonio TorresFelipe Prosper. (2006) Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia. Blood 109:8, pages 3462-3469.
Crossref
Claudia Scholl, Dimple Bansal, Konstanze Döhner, Karina Eiwen, Brian J.P. Huntly, Benjamin H. Lee, Frank G. Rücker, Richard F. Schlenk, Lars Bullinger, Hartmut Döhner, D. Gary Gilliland & Stefan Fröhling. (2007) The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesis. Journal of Clinical Investigation 117:4, pages 1037-1048.
Crossref
Rachel L. Dusek, Lisa M. Godsel, Feng Chen, Anne M. Strohecker, Spiro Getsios, Robert Harmon, Eliane J. Müller, Reto Caldelari, Vincent L. Cryns & Kathleen J. Green. (2007) Plakoglobin Deficiency Protects Keratinocytes from Apoptosis. Journal of Investigative Dermatology 127:4, pages 792-801.
Crossref
Christian Wichmann, Linping Chen, Markus Heinrich, Daniela Baus, Edith Pfitzner, Martin Zörnig, Oliver G. Ottmann & Manuel Grez. (2007) Targeting the Oligomerization Domain of ETO Interferes with RUNX1/ETO Oncogenic Activity in t(8;21)-Positive Leukemic Cells. Cancer Research 67:5, pages 2280-2289.
Crossref
Marit Kveine Nygren, Guri Døsen, Marit E. Hystad, Heidi Stubberud, Steinar Funderud & Edith Rian. (2007) Wnt3A activates canonical Wnt signalling in acute lymphoblastic leukaemia (ALL) cells and inhibits the proliferation of B-ALL cell lines. British Journal of Haematology 136:3, pages 400-413.
Crossref
Fei Yi & Bradley J. Merrill. (2007) Stem Cells and TCF Proteins: A Role for β-Catenin—Independent Functions. Stem Cell Reviews 3:1, pages 39-48.
Crossref
I Casorelli, E Tenedini, E Tagliafico, M F Blasi, A Giuliani, M Crescenzi, E Pelosi, U Testa, C Peschle, L Mele, D Diverio, M Breccia, F Lo-Coco, S Ferrari & M Bignami. (2006) Identification of a molecular signature for leukemic promyelocytes and their normal counterparts: focus on DNA repair genes. Leukemia 20:11, pages 1978-1988.
Crossref
Ming-Jer Huang, Yuan-chih Cheng, Chien-Ru Liu, Shufan Lin & H. Eugene Liu. (2006) A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia. Experimental Hematology 34:11, pages 1480-1489.
Crossref
A Tonks, L Pearn, K I Mills, A K Burnett & R L Darley. (2006) The sensitivity of human cells expressing RUNX1-RUNX1T1 to chemotherapeutic agents. Leukemia 20:10, pages 1883-1885.
Crossref
Peggy Kirstetter, Kristina Anderson, Bo T Porse, Sten Eirik W Jacobsen & Claus Nerlov. (2006) Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block. Nature Immunology 7:10, pages 1048-1056.
Crossref
Yoshihiro Baba, Takafumi Yokota, Hergen Spits, Karla P. Garrett, Shin-Ichi Hayashi & Paul W. Kincade. (2006) Constitutively Active β-Catenin Promotes Expansion of Multipotent Hematopoietic Progenitors in Culture. The Journal of Immunology 177:4, pages 2294-2303.
Crossref
J. Andres Martinez, Christopher S. Williams, Joseph M. Amann, Tiffany C. Ellis, Isabel Moreno–Miralles, M. Kay Washington, Paul Gregoli & Scott W. Hiebert. (2006) Deletion of Mtgr1 Sensitizes the Colonic Epithelium to Dextran Sodium Sulfate–Induced Colitis. Gastroenterology 131:2, pages 579-588.
Crossref
Lina Williamson, Natalia A Raess, Reto Caldelari, Anthony Zakher, Alain de Bruin, Horst Posthaus, Reinhard Bolli, Thomas Hunziker, Maja M Suter & Eliane J Müller. (2006) Pemphigus vulgaris identifies plakoglobin as key suppressor of c-Myc in the skin. The EMBO Journal 25:14, pages 3298-3309.
Crossref
F Weerkamp, J J M van Dongen & F J T Staal. (2006) Notch and Wnt signaling in T-lymphocyte development and acute lymphoblastic leukemia. Leukemia 20:7, pages 1197-1205.
Crossref
L Ysebaert, G Chicanne, C Demur, F De Toni, N Prade-Houdellier, J-B Ruidavets, V Mansat-De Mas, F Rigal-Huguet, G Laurent, B Payrastre, S Manenti & C Racaud-Sultan. (2006) Expression of β-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis. Leukemia 20:7, pages 1211-1216.
Crossref
A M Martelli, M Nyåkern, G Tabellini, R Bortul, P L Tazzari, C Evangelisti & L Cocco. (2006) Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia. Leukemia 20:6, pages 911-928.
Crossref
F De Toni, C Racaud-Sultan, G Chicanne, V Mansat-De Mas, C Cariven, F Mesange, J-P Salles, C Demur, M Allouche, B Payrastre, S Manenti & L Ysebaert. (2006) A crosstalk between the Wnt and the adhesion-dependent signaling pathways governs the chemosensitivity of acute myeloid leukemia. Oncogene 25:22, pages 3113-3122.
Crossref
C-S Chim, W W-L Chan, A Pang & Y-L Kwong. (2006) Preferential methylation of Wnt inhibitory factor-1 in acute promyelocytic leukemia: an independent poor prognostic factor. Leukemia 20:5, pages 907-909.
Crossref
Youngjin Choi, Kamaleldin E. Elagib, Lorrie L. Delehanty & Adam N. Goldfarb. (2006) Erythroid Inhibition by the Leukemic Fusion AML1-ETO Is Associated with Impaired Acetylation of the Major Erythroid Transcription Factor GATA-1. Cancer Research 66:6, pages 2990-2996.
Crossref
H. Daniel Lacorazza, Takeshi Yamada, Yan Liu, Yasuhiko Miyata, Mariela Sivina, Juliana Nunes & Stephen D. Nimer. (2006) The transcription factor MEF/ELF4 regulates the quiescence of primitive hematopoietic cells. Cancer Cell 9:3, pages 175-187.
Crossref
Jonathan D. Licht. (2006) Reconstructing a disease: What essential features of the retinoic acid receptor fusion oncoproteins generate acute promyelocytic leukemia?. Cancer Cell 9:2, pages 73-74.
Crossref
Te-Hui Liu, Aparna Raval, Shih-Shih Chen, Jennifer J. Matkovic, John C. Byrd & Christoph Plass. (2006) CpG Island Methylation and Expression of the Secreted Frizzled-Related Protein Gene Family in Chronic Lymphocytic Leukemia. Cancer Research 66:2, pages 653-658.
Crossref
Jean‐François Paré & James L. Sherley. 2006. 141 171 .
Meike Fischer, Maike Schwieger, Stefan Horn, Birte Niebuhr, Anthony Ford, Susanne Roscher, Ulla Bergholz, Mel Greaves, Jürgen Löhler & Carol Stocking. (2005) Defining the oncogenic function of the TEL/AML1 (ETV6/RUNX1) fusion protein in a mouse model. Oncogene 24:51, pages 7579-7591.
Crossref
Björn Steffen, Carsten Müller-Tidow, Joachim Schwäble, Wolfgang E. Berdel & Hubert Serve. (2005) The molecular pathogenesis of acute myeloid leukemia. Critical Reviews in Oncology/Hematology 56:2, pages 195-221.
Crossref
Hui LuoQing LiJulie O'NealFriederike KreiselMichelle M. Le BeauMichael H. Tomasson. (2005) c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations. Blood 106:7, pages 2452-2461.
Crossref
J Cammenga. (2005) Gatekeeper pathways and cellular background in the pathogenesis and therapy of AML. Leukemia 19:10, pages 1719-1728.
Crossref
Bin-Bin Liu, Lun-Xiu Qin & Yin-Kun Liu. (2005) Adult stem cells and cancer stem cells: tie in or tear apart?. Journal of Cancer Research and Clinical Oncology 131:10, pages 631-638.
Crossref

Displaying 200 of 224 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.